"About Our Practice The highly experienced rheumatologists at Arthritis Northwest PLLC in Spokane, Washington, believe that the best treatment outcomes require a comprehensive partnership involving patients, physicians, and their clinical teams. When Arthritis Northwest PLLC opened its doors in 1991, it envisioned creating a practice that combined clinical excellence and compassionate care with state-of-the-art technology. In the years since then, that dream has become a reality. Now the team at Arthritis Northwest PLLC is looking toward the future, continuing the search for new ways to deliver quality care and innovative treatment solutions to their patients."

During the past decade, Arthritis Northwest, PLLC conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 37 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 21 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arthritis Northwest, PLLC" #1 sponsor was "Eli Lilly and Company" with 10 trials, followed by "Pfizer" with 10 trials sponsored, "Bristol-Myers Squibb" with 8 trials sponsored, "Horizon Therapeutics Ireland DAC" with 4 trials sponsored and "Human Genome Sciences Inc." with 4 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arthritis Northwest, PLLC" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "Epigenesys LLC" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Arthritis Northwest, PLLC" are "Rheumatoid Arthritis" (22 trials), "Arthritis, Rheumatoid" (7 trials), "Systemic Lupus Erythematosus" (6 trials), "Gout" (5 trials) and "Lupus Erythematosus, Systemic" (5 trials). Many other conditions were trialed in "Arthritis Northwest, PLLC" in a lesser frequency.

Most popular intervention types in "Arthritis Northwest, PLLC" are "Drug" (59 trials), "Biological" (11 trials), "Other" (8 trials), "Dietary Supplement" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Ixekizumab" (5 trials), "Abatacept" (4 trials), "Methotrexate" (4 trials) and "placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "Arthritis Northwest, PLLC" are 68 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Arthritis Northwest, PLLC". undefined are not yet recruiting, 8 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in Arthritis Northwest, PLLC, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Arthritis Northwest, PLLC, 2 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 0 trials that are defined as “Not Applicable".